sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
gccaaauauaugaauucuaga | 3012 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ccugaagccuaagaaauauca | 2924 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ccugaagccuaagaaauauca | 2924 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ccugaagccuaagaaauauca | 1859 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ccugaagccuaagaaauauca | 1859 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ucuuagacaguaucauuaaaaga | 870 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ucuuagacaguaucauuaaaaga | 870 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ucuuagacaguaucauuaaaaga | 600 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ucuuagacaguaucauuaaaaga | 600 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ucuuagacaguaucauuaaaaga | 420 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ucuuagacaguaucauuaaaaga | 420 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ucuuagacaguaucauuaaaaga | 150 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ucuuagacaguaucauuaaaaga | 150 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ucuuagacaguaucauuaaaaga | 1031 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ucuuagacaguaucauuaaaaga | 1031 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ucuuagacaguaucauuaaaaga | 1305 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ucuuagacaguaucauuaaaaga | 1305 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uacuuggaauaccaaaccacaca | 462 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uacuuggaauaccaaaccacaca | 462 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uacuuggaauaccaaaccacaca | 642 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uacuuggaauaccaaaccacaca | 642 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uacuuggaauaccaaaccacaca | 192 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uacuuggaauaccaaaccacaca | 192 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uacuuggaauaccaaaccacaca | 912 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uacuuggaauaccaaaccacaca | 912 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugacuauaaggaugguuaccaua | 709 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugacuauaaggaugguuaccaua | 709 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugacuauaaggaugguuaccaua | 2690 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugacuauaaggaugguuaccaua | 2690 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugacuauaaggaugguuaccaua | 259 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugacuauaaggaugguuaccaua | 259 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaagucuuccaucagcaguga | 1428 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaagucuuccaucagcaguga | 1428 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaagucuuccaucagcaguga | 1685 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaagucuuccaucagcaguga | 1685 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaagucuuccaucagcaguga | 1455 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaagucuuccaucagcaguga | 1455 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaagucuuccaucagcaguga | 1712 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaagucuuccaucagcaguga | 1712 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uagauauuucuuaggcuucaggu | 1014 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uagauauuucuuaggcuucaggu | 1014 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uagauauuucuuaggcuucaggu | 1288 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uagauauuucuuaggcuucaggu | 1288 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaucuaccuaaagcagcauauuu | 2880 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaucuaccuaaagcagcauauuu | 2880 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuguugucacuccaugaaccacu | 1333 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuguugucacuccaugaaccacu | 1333 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuguugucacuccaugaaccacu | 1059 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuguugucacuccaugaaccacu | 1059 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugaagccuaagaaauaucuuugc | 2573 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugaagccuaagaaauaucuuugc | 2573 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aacaaucuaaugugugguuuggu | 2753 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aacaaucuaaugugugguuuggu | 2753 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uaucacugcugauggaagacuuc | 1519 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uaucacugcugauggaagacuuc | 1519 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uaucacugcugauggaagacuuc | 1776 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uaucacugcugauggaagacuuc | 1776 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uucagggaagaucuauuaaca | 1952 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uucagggaagaucuauuaaca | 1952 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uucagggaagaucuauuaaca | 3017 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uucagggaagaucuauuaaca | 3017 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uucagaaguuguuagugauuugc | 2626 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uucagaaguuguuagugauuugc | 2626 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ttaaaatctacagtcataggaat | 16 | WO2025264965A2 | Integrin ligands for extrahepatic delivery | 20,251,226 | 222 | [
"WO",
"TW"
] | null |
ttaaaatctacagtcataggaat | 16 | WO2025264965A2 | LIGANDS D'INTÉGRINE POUR ADMINISTRATION EXTRAHÉPATIQUE | 20,251,226 | 222 | [
"WO",
"TW"
] | null |
uucacacgaccauacaagccccu | 321 | CN113057959A | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uucacacgaccauacaagccccu | 321 | CN113057959A | 己酮糖激酶（KHK）iRNA组合物及其使用方法 | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uucacacgaccauacaagccccu | 221 | CN113057959A | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uucacacgaccauacaagccccu | 221 | CN113057959A | 己酮糖激酶（KHK）iRNA组合物及其使用方法 | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uucacacgaccauacaagccccu | 115 | CN113057959A | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uucacacgaccauacaagccccu | 115 | CN113057959A | 己酮糖激酶（KHK）iRNA组合物及其使用方法 | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uuguauggucgugugaggaaa | 172 | CN113057959A | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uuguauggucgugugaggaaa | 172 | CN113057959A | 己酮糖激酶（KHK）iRNA组合物及其使用方法 | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uuguauggucgugugaggaaa | 68 | CN113057959A | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uuguauggucgugugaggaaa | 68 | CN113057959A | 己酮糖激酶（KHK）iRNA组合物及其使用方法 | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uuguauggucgugugaggaaa | 272 | CN113057959A | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uuguauggucgugugaggaaa | 272 | CN113057959A | 己酮糖激酶（KHK）iRNA组合物及其使用方法 | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
ucacgcacaggaucugcuucucu | 184 | CN113057959A | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
ucacgcacaggaucugcuucucu | 184 | CN113057959A | 己酮糖激酶（KHK）iRNA组合物及其使用方法 | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
ucacgcacaggaucugcuucucu | 60 | CN113057959A | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
ucacgcacaggaucugcuucucu | 60 | CN113057959A | 己酮糖激酶（KHK）iRNA组合物及其使用方法 | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
ucacgcacaggaucugcuucucu | 284 | CN113057959A | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
ucacgcacaggaucugcuucucu | 284 | CN113057959A | 己酮糖激酶（KHK）iRNA组合物及其使用方法 | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
agaagcagauccugugcguga | 39 | CN113057959A | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
agaagcagauccugugcguga | 39 | CN113057959A | 己酮糖激酶（KHK）iRNA组合物及其使用方法 | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
agaagcagauccugugcguga | 134 | CN113057959A | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
agaagcagauccugugcguga | 134 | CN113057959A | 己酮糖激酶（KHK）iRNA组合物及其使用方法 | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
agaagcagauccugugcguga | 234 | CN113057959A | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
agaagcagauccugugcguga | 234 | CN113057959A | 己酮糖激酶（KHK）iRNA组合物及其使用方法 | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uccucuggguauuuguccaccac | 176 | CN113057959A | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uccucuggguauuuguccaccac | 176 | CN113057959A | 己酮糖激酶（KHK）iRNA组合物及其使用方法 | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uccucuggguauuuguccaccac | 276 | CN113057959A | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uccucuggguauuuguccaccac | 276 | CN113057959A | 己酮糖激酶（KHK）iRNA组合物及其使用方法 | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
acaagcacagccccuuuccucac | 110 | CN113057959A | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
acaagcacagccccuuuccucac | 110 | CN113057959A | 己酮糖激酶（KHK）iRNA组合物及其使用方法 | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
acaagcacagccccuuuccucac | 224 | CN113057959A | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
acaagcacagccccuuuccucac | 224 | CN113057959A | 己酮糖激酶（KHK）iRNA组合物及其使用方法 | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
acaagcacagccccuuuccucac | 324 | CN113057959A | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
acaagcacagccccuuuccucac | 324 | CN113057959A | 己酮糖激酶（KHK）iRNA组合物及其使用方法 | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
gccugccagaugugucugcua | 61 | CN113057959A | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | 20,210,702 | 3 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.